HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cosmetic News In Brief: J&J Incurs Third Talc Trial Loss; Lauder Acquires BECCA; More

This article was originally published in The Rose Sheet

Executive Summary

J&J again failed to convince a St. Louis jury that available evidence does not support alleged links between its Johnson’s Baby Powder and cases of ovarian cancer, marking the third costly loss in the Missouri circuit court this year; More cosmetics news in brief.

You may also be interested in...

Alternative Preservative Systems Could Give Germs, Plaintiffs A Foothold

Companies marketing “self-preserving” cosmetics could be susceptible to lawsuits at a time when “no injury” product liability class actions are on the rise. Meanwhile, “preservative-free” claims already are being challenged in the food sector where litigation trends often originate before migrating to personal care.

J&J Talc Verdict Clears Firm Of Cancer Blame; Is Tide Turning In St. Louis?

A new defense team for J&J got the job done March 3 in the same Missouri court where juries handed down hefty verdicts against the firm last year for failing to warn about talc’s alleged carcinogenicity. This time, the defendant appears to have been successful in punching holes in plaintiff experts’ testimony.

J&J Highlights Plans For Reinventing Johnson’s Baby, Globalizing Aveeno

A planned restage of Johnson’s Baby will “completely reinvent the brand,” says Jorge Mesquita, global chairman of the J&J’s consumer division. Meanwhile, the firm is working to unfetter “captive” regional brands, expanding OGX and Aveeno across the globe while bringing Le Petit Marseillais to North America, among other growth initiatives.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts